Sidley has advised China Securities (International) Corporate Finance Company Limited as sole sponsor and the underwriters. Shenzhen SDMC Technology Co., Ltd. (Ticker: 901 HK), a leading...
Shenzhen SDMC Technology Launches Hong Kong IPO Raising HKD 630 Million
Star Sports Medicine Completes Landmark Hong Kong IPO and Listing
Clifford Chance has advised Star Sports Medicine Co., Ltd. DLA Piper and Shanghai Kaiman Law Firm have advised CITIC Securities (Hong Kong) Limited and CCB International...
Novosense Microelectronics Raises HK$2.2 Billion in Hong Kong IPO and Global Offering
Paul Hastings has advised Suzhou Novosense Microelectronics Co., Ltd.; Norton Rose Fulbright advised the joint sponsors. Suzhou Novosense Microelectronics Co., Ltd. has completed a global offering...
Shuangdeng Group Debuts on Hong Kong Stock Exchange with HK$850 Million IPO
O’Melveny has advised Shuangdeng Group. Latham & Watkins has advised CICC, Huatai International, and CCBI. Shuangdeng Group Co., Ltd. has completed its initial public offering (IPO)...
iMotion Completes Second H-Share Placing Raising HK$230 Million
Kirkland & Ellis has advised iMotion Automotive Technology (Suzhou) Co., Ltd. on the deal. Sidley Asutin represented placing agents. iMotion Automotive Technology (Suzhou) Co., Ltd. has...
Cloudbreak Pharma Launches Successful IPO on Hong Kong Stock Exchange
Ashurst has advised the joint sponsors and underwriters on Cloudbreak Pharma’s global offering and Hong Kong listing. Cloudbreak Pharma Inc., a clinical-stage biotechnology company, successfully completed...
Shouhui Group Completes HK$196.8 Million Hong Kong IPO
O’Melveny has advised the underwriters on the IPO. Shouhui Group Limited has successfully completed its initial public offering on the Main Board of the Hong Kong...
Yibin Citi Commercial Bank’s HK$1.7 Billion IPO On HKEX
Clifford Chance advised Yibin City Commercial Bank on the deal, King & Wood Mallesons advised the Joint Sponsors, and Underwriters counsel. Yibin City Commercial Bank completed...
Xunfei Healthcare Technology’s $75 Million IPO On HKSE
Clifford Chance advised Xunfei Healthcare Technology Co., Ltd. DLA Piper advised joint sponsors Huatai Financial Holdings (Hong Kong) Limited, GF Capital (Hong Kong) Limited, CCB International...
Mao Geping Cosmetics’ $300 Million IPO On HKSE
Clifford Chance advised Mao Geping Cosmetics, while Paul Hastings advised the underwriters on the deal. Mao Geping Cosmetics completed its initial public offering and listing on...
China Resources Beverages Ltd’s $650 Million IPO On HKSE
Clifford Chance advised China Resources Beverages, while Paul Hastings advised the joint sponsors and the underwriters on the deal. China Resources Beverages completed its initial public...
Laopu Gold’s HK$906 Million HKEX IPO
On the deal, O’Melveny acted for Laopu Gold, Linklaters advised the underwriters. Laopu Gold Co., Ltd. completed the global offering and listing of H shares on...